Home
News/PR
Global Iodinated Contrast Media Market Size, Share & Trends Report Segmented by Agent Type (Non-Ionic, Ionic), Route of Administration (IV, IA, Oral, Rectal), Application (Cardiology, Oncology, Gastroenterology), End User (Hospitals, ASCs) Regional Forecasts 2025 to 2030

Customizations Possible - Country-wise reports, Additional company profiles, Country/Regional reports and Other Customizations. Special Discounts Available. Global Iodinated Contrast Media Market Size, Share & Trends Report Segmented by Agent Type (Non-Ionic, Ionic), Route of Administration (IV, IA, Oral, Rectal), Application (Cardiology, Oncology, Gastroenterology), End User (Hospitals, ASCs) Regional Forecasts 2025 to 2030

Global Iodinated Contrast Media Market Size, Share & Trends Report Segmented by Agent Type (Non-Ionic, Ionic), Route of Administration (IV, IA, Oral, Rectal), Application (Cardiology, Oncology, Gastroenterology), End User (Hospitals, ASCs) Regional Forecasts 2025 to 2030

The global iodinated contrast media market is set to witness a growth rate of ~6% in the next 5 years. Increasing prevalence of chronic diseases; advancements in imaging technology; growing demand for non-invasive procedures; expanding healthcare infrastructure in emerging markets; and rising R&D efforts for new formulations are some of the key factors driving the iodinated contrast media market. To learn more about the research report, download a sample report.

iodinated-contrast-media-market

transparent

600

#12bece

‌
DESCRIPTION
TABLE OF CONTENT
METHODOLODY
SAMPLE DELIVERABLES

Overview

Iodinated contrast media are radiopaque substances used in diagnostic imaging procedures to enhance the visibility of internal structures and tissues. Composed of iodine, a high atomic number element, these agents absorb X-rays effectively, improving image contrast in techniques such as computed tomography (CT), angiography, and fluoroscopy. They help differentiate between normal and abnormal tissues, making them invaluable in diagnosing conditions like cardiovascular diseases, cancer, and gastrointestinal disorders. Available in various formulations, including ionic, non-ionic, and low-osmolar types, iodinated contrast media are designed to minimize side effects while providing optimal diagnostic clarity, ensuring safe and effective imaging in clinical practice.

Iodinated Contrast Media Market

To learn more about this report, download the PDF brochure

Increasing prevalence of chronic diseases to propel market demand

The rising prevalence of chronic diseases, such as cardiovascular disorders, cancer, and gastrointestinal conditions, is significantly driving the iodinated contrast media market. These diseases often require advanced diagnostic imaging techniques like CT scans and angiography, where iodinated contrast agents enhance image clarity and diagnostic accuracy. Aging populations, more prone to chronic illnesses, further amplify demand for these procedures. Additionally, early diagnosis and disease monitoring initiatives in healthcare systems worldwide are boosting the adoption of imaging technologies, solidifying the role of iodinated contrast media in ensuring precise visualization of internal structures for effective clinical decision-making.

Advancements in imaging technology are driving the market growth

Advancements in imaging technology are a major driver of the iodinated contrast media market. Innovations such as dual-energy CT, spectral imaging, and automated injector systems have improved the accuracy, efficiency, and safety of diagnostic imaging procedures. These technologies enhance the ability of iodinated contrast agents to deliver clearer and more detailed images, aiding in the precise diagnosis of complex conditions like cancer and cardiovascular diseases. Additionally, improved imaging systems reduce radiation exposure and optimize contrast agent usage, making procedures safer and more efficient. Such advancements are increasing the adoption of iodinated contrast media in clinical settings globally.

Iodinated Contrast Media Market - Segmentation

To learn more about this report, download the PDF brochure

Competitive Landscape Analysis

The global iodinated contrast media market is marked by the presence of established and emerging market players such as GE Healthcare; Bayer AG; Bracco; Lantheus; Guerbet; Fujifilm Holdings; Jiangsu Hengrui Pharmaceuticals Co., Ltd.; Zhejiang Starry Pharmaceutical Co., Ltd.; JB Pharma; and Trivitron Healthcare; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Report Scope

Report Metric	Details
Base Year Considered	2024
Historical Data	2023 - 2024
Forecast Period	2025 - 2030
Growth Rate	~6%
Market Drivers	Increasing prevalence of chronic diseases Advancements in imaging technology Growing demand for non-invasive procedures Expanding healthcare infrastructure in emerging markets Rising R&D efforts for new formulations
Attractive Opportunities	Rising adoption in emerging economies Development of low-osmolar and iso-osmolar contrast agents Increased focus on oncology applications
Segment Scope	Agent Type, Route of Administration, Application, End User
Regional Scope	North America (US & Canada) Europe (UK, Germany, France, Italy, Spain, Rest of Europe) Asia Pacific (China, India, Japan, Rest of Asia Pacific) Latin America Middle East & Africa
Key Companies Mapped	GE Healthcare; Bayer AG; Bracco; Lantheus; Guerbet; Fujifilm Holdings; Jiangsu Hengrui Pharmaceuticals Co., Ltd.; Zhejiang Starry Pharmaceutical Co., Ltd.; JB Pharma; and Trivitron Healthcare; among others
Report Highlights	Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

Global Iodinated Contrast Media Market Segmentation

This report by Medi-Tech Insights provides the size of the global iodinated contrast media market at the regional- and country-level from 2023 to 2030. The report further segments the market based on agent type, route of administration, application, and end user.

Market Size & Forecast (2023-2030), By Agent Type, USD Million

Non-Ionic
Ionic
Others

Market Size & Forecast (2023-2030), By Route of Administration, USD Million

Intravenous (IV)
Intra-arterial (IA)
Oral
Rectal
Others

Market Size & Forecast (2023-2030), By Application, USD Million

Cardiology
Neurology
General Surgery
Oncology
Gastroenterology
Others

Market Size & Forecast (2023-2030), By End User, USD Million

Hospitals and Clinics
Diagnostic Imaging Centers
Ambulatory Surgical Centers (ASCs)
Others

Market Size & Forecast (2023-2030), By Region, USD Million

North America
- US
- Canada
Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
Latin America
Middle East & Africa

Key Strategic Questions Addressed

What is the market size & forecast of the iodinated contrast media market?
What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the iodinated contrast media market?
What are the key trends defining the market?
What are the major factors impacting the market?
What are the opportunities prevailing in the market?
Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
Who are the major players operating in the market?
What are the key strategies adopted by players?

Introduction
- Introduction
- Market Scope
  - Market Definition
  - Segments Covered
  - Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
  - Bottom-Up Approach
  - Top-Down Approach
- Market Forecasting
Executive Summary
- Iodinated Contrast Media Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
Market Overview
- Market Dynamics
  - Drivers
    - Increasing prevalence of chronic diseases
    - Advancements in imaging technology
    - Growing demand for non-invasive procedures
    - Expanding healthcare infrastructure in emerging markets
    - Rising R&D efforts for new formulations
  - Restraints
    - Side effects and adverse reactions
    - Stringent regulatory requirements
    - Competition from alternative contrast media
  - Opportunities
    - Rising adoption in emerging economies
    - Development of low-osmolar and iso-osmolar contrast agents
    - Increased focus on oncology applications
  - Key Market Trends
    - Evolving regulatory landscape
    - Sustainability efforts in product development
  - Unmet Market Needs
  - Industry Speaks

Global Iodinated Contrast Media Market Size & Forecast (2023-2030), By Agent Type, USD Million
- Introduction
- Non-Ionic
- Ionic
- Others
Global Iodinated Contrast Media Market Size & Forecast (2023-2030), By Route of Administration, USD Million
- Introduction
- Intravenous (IV)
- Intra-arterial (IA)
- Oral
- Rectal
- Others
Global Iodinated Contrast Media Market Size & Forecast (2023-2030), By Application, USD Million
- Introduction
- Cardiology
- Neurology
- General Surgery
- Oncology
- Gastroenterology
- Others
Global Iodinated Contrast Media Market Size & Forecast (2023-2030), By End User, USD Million
- Introduction
- Hospitals and Clinics
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers (ASCs)
- Others
Global Iodinated Contrast Media Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Iodinated Contrast Media Market Size & Forecast (2023-2030), By Country, USD Million
  - US
    - Market Size & Forecast, By Agent Type (USD Million)
    - Market Size & Forecast, By Route of Administration (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - Canada
    - Market Size & Forecast, By Agent Type (USD Million)
    - Market Size & Forecast, By Route of Administration (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By End User (USD Million)
- Europe Iodinated Contrast Media Market Size & Forecast (2023-2030), By Country, USD Million
  - UK
    - Market Size & Forecast, By Agent Type (USD Million)
    - Market Size & Forecast, By Route of Administration (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - Germany
    - Market Size & Forecast, By Agent Type (USD Million)
    - Market Size & Forecast, By Route of Administration (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - France
    - Market Size & Forecast, By Agent Type (USD Million)
    - Market Size & Forecast, By Route of Administration (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - Italy
    - Market Size & Forecast, By Agent Type (USD Million)
    - Market Size & Forecast, By Route of Administration (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - Spain
    - Market Size & Forecast, By Agent Type (USD Million)
    - Market Size & Forecast, By Route of Administration (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - Rest of Europe
    - Market Size & Forecast, By Agent Type (USD Million)
    - Market Size & Forecast, By Route of Administration (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By End User (USD Million)
- Asia Pacific (APAC) Iodinated Contrast Media Market Size & Forecast (2023-2030), By Country, USD Million
  - China
    - Market Size & Forecast, By Agent Type (USD Million)
    - Market Size & Forecast, By Route of Administration (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - Japan
    - Market Size & Forecast, By Agent Type (USD Million)
    - Market Size & Forecast, By Route of Administration (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - India
    - Market Size & Forecast, By Agent Type (USD Million)
    - Market Size & Forecast, By Route of Administration (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By End User (USD Million)
  - Rest of Asia Pacific
    - Market Size & Forecast, By Agent Type (USD Million)
    - Market Size & Forecast, By Route of Administration (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By End User (USD Million)
- Latin America (LATAM) Iodinated Contrast Media Market Size & Forecast (2023-2030), USD Million
  - Market Size & Forecast, By Agent Type (USD Million)
  - Market Size & Forecast, By Route of Administration (USD Million)
  - Market Size & Forecast, By Application (USD Million)
  - Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Iodinated Contrast Media Market Size & Forecast (2023-2030), USD Million
  - Market Size & Forecast, By Agent Type (USD Million)
  - Market Size & Forecast, By Route of Administration (USD Million)
  - Market Size & Forecast, By Application (USD Million)
  - Market Size & Forecast, By End User (USD Million)

Competitive Landscape
- Key Players and their Competitive Positioning
  - Key Player Comparison
  - Segment-wise Player Mapping
  - Market Share Analysis (2024)
  - Company Categorization Matrix
    - Dominants/Leaders
    - New Entrants
    - Emerging Players
    - Innovative Players
  - Key Strategies Assessment, By Player (2022-2025)
    - New Product Launches
    - Partnerships, Agreements, & Collaborations
    - Mergers & Acquisitions
    - Geographic Expansion

Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

GE Healthcare
Bayer AG
Bracco
Lantheus
Guerbet
Fujifilm Holdings
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Zhejiang Starry Pharmaceutical Co., Ltd.
JB Pharma
Trivitron Healthcare
Other Prominent Players

Note: *Indicative list

**For listed companies

The study has been compiled based on extensive primary and secondary research.

Secondary Research (Indicative List)

Iodinated Contrast Media Market - Secondary Research

Primary Research

To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.

Supply Side Stakeholders:

Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants

Demand Side Stakeholders:

Stakeholders from Introduction, Hospitals and Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers (ASCs); and Others

Breakdown of Primary Interviews

Iodinated Contrast Media Market - Primary Interviews

Market Size Estimation

Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts

Data Triangulation

Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data

Iodinated Contrast Media Market - Sample Deliverables

Iodinated Contrast Media Market - Key Players

Get a sample report for competitive landscape analysis

Features of the Report

Comprehensive Market Coverage
Market Size and Forecast
Geographic & Segment Deep Dives
Strategic Insights & Competitive Landscape
Timely & Updated Data
Growth Indicators & Future Outlook
Quick Turnaround on Queries
Analyst Support
Report Customization Available
Reports in PDF & Excel

Order Report